Thomas C. Reynolds, Chief Medical Officer at SEATTLE GENETICS INC /WA (SGEN), sold 7,290 shares at $29.84 ($219K) on 2013-01-25, disclosed to the SEC on 2013-01-29.
Scheduled sale ($219k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.84 | 2,083 | $62K | 28.3% |
| 2 | $30.19 | 1,027 | $31K | 14.1% |
| 3 | $30.19 | 1,576 | $48K | 21.7% |
| 4 | $30.19 | 2,604 | $79K | 35.8% |
| Total | $30.09 avg | 7,290 | $219K | 100% |
| Filing → |
| SGEN | SELL | 2012-12-10 | $1.7M | — | Filing → |
| SGEN | SELL | 2012-12-06 | $1.0M | — | Filing → |
| SGEN | SELL | 2012-12-03 | $1.0M | — | Filing → |